Thyroid disease: Effects on cardiovascular function

Trends in Endocrinology and Metabolism

Volumn 7, Issue 2, 1996, Pages 50-54

  Franklyn, Jayne A ^b   Gammage, Michael D ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RESPONSE; CARDIOVASCULAR SYSTEM; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART FAILURE; HEART WORK; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; THYROID DISEASE;

EID: 0029868578     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/1043-2760(95)00227-8     Document Type: Short Survey

References (46)

1. Arai M, Otsu K, Maclennan DH, Alpert N, Periasamy M: 1991. Effect of thyroid hormone on the expression of mRNA encoding sarcoplasmic reticulum proteins. Circ Res 69:266-276.
2. Bell GM, Sawers JSA, Forfar JC, Doig A, Toft AD: 1983. The effect of minor increments in plasma thyroxine on heart rate and urinary sodium excretion. Clin Endocrinol (Oxf) 18:511-516.
3. Bing RF, Briggs RSJ, Burden AC, Russell GI, Swales JD, Thurston H: 1980. Reversible hypertension and hypothyroidism. Clin Endocrinol (Oxf) 13:339-3442.
4. Biondi B, Fazio S, Carella C, et al.: 1993. Cardiac effects of long term thyrotropin suppressive therapy with levothyroxine. J Clin Endocrinol Metab 77:334-338.
5. Biondi R, Carella C, Sabatini D, et al.: 1994. Control of adrenergic overactivity by β-blockade improves the quality of life in patients receiving long term suppressive therapy with levothyroxine. J Clin Endocrinol Metab 78:1028-1033.
6. Brent G, Moore DD, Larsen PR: 1991. Thyroid hormone regulation of gene expression. Annu Rev Physiol 53:17-35.
7. Cavallo A, Joseph CJ, Casta A: 1984. Cardiac complications in juvenile hyperthyroidism. Am J Dis Child 138:479.
8. Ching GW, Franklyn JA, Stallard TJ, Daykin J, Sheppard MC, Gammage MD: 1995. Therapy and thyrotoxicosis. Br Heart J (in press).
9. Engler H, Reisen WF: 1993. Effect of thyroid function on concentrations of lipoprotein (a). Clin Chem 39:2466-2469.
10. Feldman T, Borow KM, Sarne DH, Neumann A, Lang RM: 1986. Myocardial mechanics in hyperthyroidism: importance of left ventricular loading conditions, heart rate and contractile state. J Am Coll Cardiol 7:967-974.
11. Forfar JC, Muir AL, Sawers SA, Toft AD: 1982a. Abnormal left ventricular function in hyperthyroidism. N Engl J Med 307: 1165-1170.
12. Forfar JC, Muir AL, Toft AD: 1982b. Left ventricular function in hypothyroidism. Br Heart J 48:278-284.
13. Franklyn JA, Daykin J, Betteridge J, et al.: 1993. Thyroxine replacement therapy and circulating lipid concentrations. Clin Endocrinol (Oxf) 38:453-459.
14. Gay RG, Raya TE, Lancaster LD, Lee RW, Morkin E, Goldman S: 1988. Effects of thyroid state upon venous compliance and left ventricular performance in rats. Am J Physiol 254:H81-H88.
15. Gibson JG, Harris AW: 1939. Clinical studies of the blood volume: V. Hyperthyroidism and myxedema. J Clin Invest 18:59-65.
16. Graettinger JS, Muenster JJ, Checchia CS, Grissom RL, Campbell JA: 1958. A correlation of clinical and hemodynamic studies in patients with hypothyroidism. J Clin Invest 18:502-510.
17. Jennings PE, O'Malley BP, Griffin KE, Northover B, Rosenthal FD: 1984. Relevance of increased serum thyroxine concentrations associated with normal serum triiodothyronine values in hypothyroid patients receiving thyroxine: a case for tissue thyrotoxicosis. Br Med J 289:1645-1647.
18. Keating FR Jr, Parkin JW, Selby JB, Dickinson LS: 1961. Treatment of heart disease associated with myxedema. Prog Cardiovasc Dis 3:364-381.
19. Klein I: 1989. Thyroid hormone and high blood pressure. In Laragh JH, Brenner BM, Kaplan NM, eds. Endocrine Mechanisms in Hypertension. New York, Raven, pp 61-79.
20. Klein I, Hong C: 1986. Effects of thyroid hormone on cardiac size and myosin content of the heterotopically transplanted rat heart. J Clin Invest 77:1694-1698.
21. Kutty KM, Bryant DG, Farid NR: 1978. Serum lipids in hypothyroidism. J Clin Endocrinol Metab 46:55-56.
22. Ladenson PW, Sherman SI, Ray PE, Feldman AM: 1992. Reversible alterations in myocardial gene expression in a young man with dilated cardiomyopathy and hypothyroidism. Proc Natl Acad Sci USA 89:5251-5255.
23. Leese GP, Jung RT, Guthrie C, Waugh N, Browning MCK: 1992. Morbidity in patients on L-thyroxine: a comparison of those with a normal TSH to those with suppressed TSH. Clin Endocrinol (Oxf) 37:500-503.
24. Martin WH III, Spina RJ, Korte E: 1992. Effect of hyperthyroidism of short duration upon on cardiac sensitivity to β-adrenergic stimulation. J Am Coll Cardiol 19:1185-1191.
25. Mintz G, Pizzarello R, Klein I: 1991. Enhanced left ventricular diastolic function in hyperthyroidism: non-invasive assessment and response to treatment. J Clin Endocrinol Metab 73:146-150.
26. Morgan HE, Baker KM: 1991. Cardiac hypertrophy: mechanical, neural, and endocrine dependence. Circulation 83:13-25.
27. Olshausen KV, Bischoff S, Kahaly G, et al.: 1989. Cardiac arrhythmias and heart rate in hyperthyroidism. Am J Cardiol 63:930-933.
28. Parle JV, Franklyn JA, Cross KW, Jones SC, Sheppard MC: 1991a. Prevalence and follow-up of abnormal TSH concentrations in the elderly in the United Kingdom. Clin Endocrinol (Oxf) 34:77-85.
29. Parle JV, Franklyn JA, Sheppard MC: 1991b. Thyroxine replacement therapy. Lancet 337:171.
30. Parry CHJ: 1825. Palpitation of the heart in connexion with enlargement of the thyroid: collections from the unpublished papers of Caleb Hillier Parry. Dis Heart 2:111-165.
31. Petersen K, Bengtsson C, Lapidus L, Lindstedt G, Nystrom E: 1990. Morbidity, mortality, and quality of life for patients treated with levothyroxine. Arch Intern Med 150: 2077-2081.
32. Polikar R, Burger AG, Scherrer U, Nicod P: 1993. The thyroid and heart. Circulation 87:1435-1441.
33. Roti E, Minelli R, Gardini E, Braverman LE: 1993. The use and misuse of thyroid hormone. Endocr Rev 14:401-23.
34. Santos AD, Miller RP, Mathew PK, Wallace WA, Cave WT, Hinojosa L: 1980. Echocardiographic characterization of the reversible cardiomyopathy of hypothyroidism. Am J Med 68:675-682.
35. Saruta T, Kitajima W, Hayashi M, Kato E, Matsuki S: 1980. Renin and aldosterone in hypothyroidism. Clin Endocrinol (Oxf) 12: 483-489.
36. Sawin CT, Geller A, Wolf PA, et al.: 1994. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 331:1249-52.
37. Segal J: 1990. Calcium is the first messenger for the action of thyroid hormone at the level of the plasma membrane: first evidence for an acute effect of thyroid hormone on calcium uptake in the heart. Endocrinology 126:2693-2702.
38. Singh BN, Vaughan-Williams EM: 1970. The effect of amiodarone, a new anti-anginal drug, on cardiac muscle. Br J Clin Pharmacol 39:657-667.
39. Smallridge RC, Goldman MH, Raines K, Jones S, Van Nostrand D: 1987. Rest and exercise left ventricular ejection fraction before and after therapy in young adults with hyperthyroidism and hypothyroidism. Am J Cardiol 60:929-931.
40. Steinberg AD: 1968. Myxedema and coronary artery disease: a comparative autopsy study. Ann Intern Med 68:338-344.
41. Theilen EO, Wilson WR: 1967. Hemodynamic effects of peripheral vasoconstriction in normal and thyrotoxic subjects. J Appl Physiol 22:207-210.
42. Valcalvi R, Menozzi C, Roti E, et al.: 1992. Sinus node function in hyperthyroid patients. J Clin Endocrinol Metab 75:239-242.
43. Venkatesh N, Kuhle WGK, Feld GK, Singh BN: 1988. Hypothyroidism elevates ventricular fibrillation threshold in rabbits [abst]. J Am Coll Cardiol 1:41.
44. Williams RS, Lefkowitz RJ: 1983. The effect of thyroid hormones on adrenergic receptors. In Oppenheimer JH, ed. Molecular Basis of Thyroid Hormone Action. London, Academic, pp 325-349.
45. Woeber KA: 1992. Thyrotoxicosis and the heart. N Engl J Med 327:94-98.
46. Zimmerman J, Yahalom J, Bar-On H: 1983. Clinical spectrum of pericardial effusion as the presenting feature of hypothyroidism. Am Heart J 106:770-771.